Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MHDr. Madeleine Heldman

    Dr. Madeleine Heldman

    Infectious Disease · Transplant/Immunocompromised States
    Duke University Health System
    madeleine

    Research

    Multisystem progression on fosmanogepix despite activity: a call for expanding clinical research on novel antifungals

    2026

    Via ASM Case Reports

    Research

    Cytomegalovirus infections in thoracic organ transplant recipients: Updates on prevention, treatment, and immune monitoring

    2026

    Via JHLT Open

    Research

    Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy

    2026

    Via Transplant Infectious Disease

    Research

    Immunocompromised Host Infectious Diseases: A Recommended Educational Content Outline for Advanced Practice Providers

    2026

    Via Transplant Infectious Disease

    Research

    Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk (cytomegalovirus donor seropositive, recipient seronegative) solid organ transplant recipients with prolonged follow-up: A 10-year experience

    2026

    Via American Journal of Transplantation

    Research

    Contemporary Cytomegalovirus (CMV) Infections in Low-Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D-/R-): Time to Reexamine Donor CMV Serostatus

    2025

    Via Clinical Transplantation

    Research

    The iciHHV-6 Sense: Sensing the Source and Relevance of Human Herpesvirus 6 (HHV-6) DNA in the Transplant Recipient With Inherited Chromosomally Integrated HHV-6

    2025

    Via The Journal of Infectious Diseases

    Research

    Outcomes of lung transplantation from SARS-CoV-2 positive donors during the Omicron wave

    2025

    Via JHLT Open

    Research

    HOPE in every breath and heartbeat: Understanding transplant eligibility, access barriers, and clinical outcomes in thoracic transplantation in persons with HIV

    2025

    Via JHLT Open

    Research

    Talk About a Bad Reputation: Is It OK to Continue Trimethoprim-Sulfamethoxazole Prophylaxis in the Face of Hyper K

    2025

    Via Transplant Infectious Disease

    Oct 6, 2025Journal Article

    Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation.

    ​

    Written by 1 Roon author & 2 others

    Via Clinical Infectious Diseases
    Dec 24, 2025Journal Article

    Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts.

    ​

    Written by 1 Roon author & 9 others

    Via Clinical Infectious Diseases

    Research

    Influenza Antivirals for Prevention and Treatment in Immunocompromised People

    2025

    Via The Journal of Infectious Diseases

    Research

    Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant

    2025

    Via The Journal of Heart and Lung Transplantation

    Research

    Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell Transplant

    2024

    Via The Journal of Infectious Diseases